Literature DB >> 7574468

Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease.

E Levy-Lahad1, A Lahad, E M Wijsman, T D Bird, G D Schellenberg.   

Abstract

The effect of the apolipoprotein E (APOE) epsilon 4 allele on age of onset was analyzed in two groups of families with early-onset Alzheimer's disease (AD), (1) Volga German (VG) kindreds, in which AD is caused by an unknown locus and (2) early-onset non-VG families showing evidence of linkage to chromosome 14. The epsilon 4 allele did not have a detectable effect on age of onset in either group. This finding suggests some forms of early-onset familial AD are not modifiable by APOE status, or that AD can be caused by APOE-independent pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574468     DOI: 10.1002/ana.410380420

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.

Authors:  R A S Robinson; M B Lange; R Sultana; V Galvan; J Fombonne; O Gorostiza; J Zhang; G Warrier; J Cai; W M Pierce; D E Bredesen; D A Butterfield
Journal:  Neuroscience       Date:  2011-01-09       Impact factor: 3.590

3.  Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E.

Authors:  A A Golabek; E Kida; M Walus; C Perez; T Wisniewski; C Soto
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

4.  Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.

Authors:  Adam C Naj; Gary W Beecham; Eden R Martin; Paul J Gallins; Eric H Powell; Ioanna Konidari; Patrice L Whitehead; Guiqing Cai; Vahram Haroutunian; William K Scott; Jeffery M Vance; Michael A Slifer; Harry E Gwirtsman; John R Gilbert; Jonathan L Haines; Joseph D Buxbaum; Margaret A Pericak-Vance
Journal:  PLoS Genet       Date:  2010-09-23       Impact factor: 5.917

Review 5.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

6.  Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.

Authors:  C A Lynch; J Brazil; B Cullen; D Coakley; M Gill; B A Lawlor; Z Hawi
Journal:  Ir J Med Sci       Date:  2007-12-05       Impact factor: 1.568

7.  The impact of the human genome project on complex disease.

Authors:  Jessica N Cooke Bailey; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genes (Basel)       Date:  2014-07-16       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.